- Filed
- Aug 30, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 29, 2024 | 17.57M sh |
| Short Term Investments | Q2 2024 · Jul 31, 2024 | $84.94M |
| Short Term Investments | Q2 2024 · Jan 31, 2024 | $155.26M |
| Cash And Equivalents | Q2 2024 · Jul 31, 2024 | $261.04M |
| Cash And Equivalents | Q2 2024 · Jan 31, 2024 | $223.4M |
| Stockholders Equity | Q2 2024 · Jul 31, 2024 | $539.63M |
| Stockholders Equity | Q2 2024 · Jan 31, 2024 | $513.92M |
| Current Liabilities | Q2 2024 · Jul 31, 2024 | $51.91M |
| Current Liabilities | Q2 2024 · Jan 31, 2024 | $66.26M |
| Current Assets | Q2 2024 · Jul 31, 2024 | $418.91M |
| Current Assets | Q2 2024 · Jan 31, 2024 | $452.1M |
| Total Assets | Q2 2024 · Jul 31, 2024 | $680.01M |
| Total Assets | Q2 2024 · Jan 31, 2024 | $664.8M |
| Shares Diluted | Q2 2024 · Jul 31, 2023 | 17.46M sh |
| Shares Diluted | Q2 2024 · Jul 31, 2023 | 17.43M sh |
| Capex | Q2 2024 · Jul 31, 2023 | $8.17M |
| Operating Cash Flow restated | Q2 2024 · Jul 31, 2023 | $6.63M |
| Eps Diluted | Q2 2024 · Jul 31, 2023 | $0.52 |
| Eps Diluted | Q2 2024 · Jul 31, 2023 | $0.82 |
| Eps Basic | Q2 2024 · Jul 31, 2023 | $0.52 |
| Eps Basic | Q2 2024 · Jul 31, 2023 | $0.82 |
| Sga Expense | Q2 2024 · Jul 31, 2023 | $8.62M |
| Sga Expense | Q2 2024 · Jul 31, 2023 | $14.39M |
| Gross Profit | Q2 2024 · Jul 31, 2023 | $18.35M |
| Gross Profit | Q2 2024 · Jul 31, 2023 | $28.52M |